Which peptides for recovery carry the most published in-vitro and animal-model research? A structured Kiwi Peps reference covering BPC-157, TB-500, GHK-Cu, thymosin and GH-axis blends.
Research literature on peptides for recovery converges on four functional classes: gastric-juice-derived stable peptides (BPC-157), actin-sequestering peptides (TB-500 / Thymosin β4 fragment), copper-complex signalling peptides (GHK-Cu) and thymic-immune modulators (Thymosin α1). Growth-hormone-axis reference blends such as CJC-1295 + ipamorelin are frequently cited alongside these compounds for context in published tissue-remodelling and connective-tissue research models.
This Kiwi Peps reference summarises the peptides for recovery most cited in the published in-vitro and animal-model literature, the endpoints researchers typically record, and the analytical documentation expected on every batch COA.
Peptides for recovery — reference matrix
| Compound | Class | Primary research context | Reference endpoints |
|---|---|---|---|
| BPC-157 | Gastric-derived stable pentadecapeptide | Vascular, mucosal and connective-tissue models | VEGFR2 signalling, fibroblast outgrowth, collagen markers |
| TB-500 | Actin-sequestering Tβ4 fragment | Cytoskeletal and tissue-model repair | Cell-migration assays, actin dynamics |
| GHK-Cu | Copper-complex signalling tripeptide | Matrix remodelling and antioxidant expression | Collagen I/III transcripts, SOD, decorin |
| Thymosin α1 | Thymic 28-residue peptide | Immune-modulation research models | TLR signalling, cytokine profiling |
| CJC-1295 + ipamorelin blend | GHRH + GHSR dual-axis reference | GH-axis exposure and IGF-1 kinetics | IGF-1, pulse amplitude |
How the research literature groups these peptides for recovery
- Structural repair models — BPC-157 and TB-500 dominate the citation count.
- Dermal and matrix remodelling — GHK-Cu is the reference compound.
- Immune-model research — Thymosin α1 is the most cited reference peptide.
- Systemic GH-axis exposure references — CJC-1295 and ipamorelin (see the dedicated blend profile).
COA verification for peptides for recovery
- ≥98% HPLC purity for the target peptide.
- LC-MS confirmation of monoisotopic mass.
- Residual solvent and water-content documentation.
- Batch identifier that matches the outer-box and inner-vial labelling.
Peptides for recovery FAQ
Which peptides are most cited in recovery research?
BPC-157 and TB-500 dominate published in-vitro and animal-model literature on structural repair. GHK-Cu leads dermal-matrix remodelling research. Thymosin α1 leads immune-model references.
Can BPC-157 and TB-500 be blended for recovery research?
Yes — the two are frequently pre-blended as the 'Wolverine' research reference because their mechanisms (VEGFR2 signalling and actin dynamics) are independent.
Are peptides for recovery legal to purchase in New Zealand?
Research-grade peptides are legal to buy for laboratory research use in New Zealand. They are not for human or veterinary use.
Where can New Zealand researchers buy recovery-research peptides?
Kiwi Peps supplies BPC-157, TB-500, GHK-Cu and related recovery-research references at ≥98% HPLC purity with third-party COA and same-day domestic dispatch.
